case_images: PMC10196249_01
case_images: Chest x-ray images of the four patients. (1) CASE 1: increased and blurred bilateral lung markings. (2) CASE 2: increased and blurred bilateral lung markings. (3) CASE 3: increased and blurred bilateral lung markings and patchy shadows on the right upper lung field. (4) CASE 4: increased and blurred bilateral lung markings.
case_images: fped-11-1179402-g001.jpg
case_images: PMC10196249_04_fped-11-1179402-g001.jpg
case_images: F1
case_images: Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1).
case_images: ALT level trend over time of the four patients. All patients had normal liver function at the initial stage of the course. ALT elevation (>41 U/L) occurred 5 to 8 days after the first onset of fever, then reached 3 to 10 folds of the upper range. All the patients received hepatoprotective therapy, and transaminase levels gradually decreased to the normal range after 2 to 3 weeks.
case_images: fped-11-1179402-g002.jpg
case_images: PMC10196249_04_fped-11-1179402-g002.jpg
case_images: F2
case_images: Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus.
case_images: PMC10196249_02
case_images: Chest x-ray images of the four patients. (1) CASE 1: increased and blurred bilateral lung markings. (2) CASE 2: increased and blurred bilateral lung markings. (3) CASE 3: increased and blurred bilateral lung markings and patchy shadows on the right upper lung field. (4) CASE 4: increased and blurred bilateral lung markings.
case_images: fped-11-1179402-g001.jpg
case_images: PMC10196249_04_fped-11-1179402-g001.jpg
case_images: F1
case_images: Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1).
case_images: ALT level trend over time of the four patients. All patients had normal liver function at the initial stage of the course. ALT elevation (>41 U/L) occurred 5 to 8 days after the first onset of fever, then reached 3 to 10 folds of the upper range. All the patients received hepatoprotective therapy, and transaminase levels gradually decreased to the normal range after 2 to 3 weeks.
case_images: fped-11-1179402-g002.jpg
case_images: PMC10196249_04_fped-11-1179402-g002.jpg
case_images: F2
case_images: Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus.
case_images: PMC10196249_03
case_images: Chest x-ray images of the four patients. (1) CASE 1: increased and blurred bilateral lung markings. (2) CASE 2: increased and blurred bilateral lung markings. (3) CASE 3: increased and blurred bilateral lung markings and patchy shadows on the right upper lung field. (4) CASE 4: increased and blurred bilateral lung markings.
case_images: fped-11-1179402-g001.jpg
case_images: PMC10196249_04_fped-11-1179402-g001.jpg
case_images: F1
case_images: Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1).
case_images: ALT level trend over time of the four patients. All patients had normal liver function at the initial stage of the course. ALT elevation (>41 U/L) occurred 5 to 8 days after the first onset of fever, then reached 3 to 10 folds of the upper range. All the patients received hepatoprotective therapy, and transaminase levels gradually decreased to the normal range after 2 to 3 weeks.
case_images: fped-11-1179402-g002.jpg
case_images: PMC10196249_04_fped-11-1179402-g002.jpg
case_images: F2
case_images: Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus.
case_images: PMC10196249_04
case_images: Chest x-ray images of the four patients. (1) CASE 1: increased and blurred bilateral lung markings. (2) CASE 2: increased and blurred bilateral lung markings. (3) CASE 3: increased and blurred bilateral lung markings and patchy shadows on the right upper lung field. (4) CASE 4: increased and blurred bilateral lung markings.
case_images: fped-11-1179402-g001.jpg
case_images: PMC10196249_04_fped-11-1179402-g001.jpg
case_images: F1
case_images: Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1).
case_images: ALT level trend over time of the four patients. All patients had normal liver function at the initial stage of the course. ALT elevation (>41 U/L) occurred 5 to 8 days after the first onset of fever, then reached 3 to 10 folds of the upper range. All the patients received hepatoprotective therapy, and transaminase levels gradually decreased to the normal range after 2 to 3 weeks.
case_images: fped-11-1179402-g002.jpg
case_images: PMC10196249_04_fped-11-1179402-g002.jpg
case_images: F2
case_images: Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus.